United Kingdom · Biotechnology startup

Epoch Biodesign

Epoch Biodesign is a London-based synthetic biology company founded in 2019.

Funding reportedLast round: Undisclosed round

BiotechnologyLondon, United Kingdom

About Epoch Biodesign

Epoch Biodesign is a London-based synthetic biology company founded in 2019.

The company focuses on using AI-designed enzymes to facilitate infinite, virgin-quality recycling of mixed plastics and blended textiles, starting with nylon 6,6. Their mission is to address climate challenges by breaking down complex waste into high-purity chemical building blocks, promoting a circular economy for difficult-to-recycle materials. The company employs a proprietary enzymatic biorecycling process that deconstructs plastic waste at the molecular level, producing recycled nylon 6,6 that matches the quality of virgin plastic. Epoch Biodesign serves B2B clients across various industries, including apparel, automotive, and packaging, providing sustainable materials and low-carbon chemical building blocks. With a team of around 32 scientists and engineers, the company is building a multi-tonne demo facility aimed at scaling production to 150 metric tonnes annually by 2026.

What company datasets say Epoch Biodesign raised

Funding, as reported

Reported in all16Min the source's currency
Rounds9
Last roundUndisclosed round
Last round size12M
Last round dateJan 2024
Investors listed10

Funding filed with regulators

Epoch Biodesign filed 5 raises, $29M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Mar 2025$1.1MUK share allotment
  2. Jan 2025$1.4MUK share allotment
  3. Dec 2024$2.4MUK share allotment
  4. Nov 2024$13MUK share allotment
  5. Dec 2021$11MUK share allotment

On 5 portfolio pages

Investors who name them

Each firm lists Epoch Biodesign on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

The company, in detail

What they build

Known for

nylon recyclingpolyester recyclingchemical depolymerizationlow-temperature processesbiotech for waste managementconsumer goods & retailmanufacturingsustainable materialsmaterials sciencewaste transformationclimate solutionsmolecular recyclingfossil carbon displacementwaste managementai and synthetic biologyplastic waste

Built with from their website

DockerAmazon CloudFrontWordPress.orgSalesforce CRM AnalyticsGoogle WorkspaceCloudFlareViewport MetaLinkedIn AdsEchoWebflow Hosting

+8 more

AIGoogle MeetAct!CloudFlare CDNMistMobile FriendlyOpen GraphjQuery

Sector
Biotechnology
Industry code
NAICS 32519, 541714, 325220, SIC 2899, 8731, 2824
Region
England
Revenue
1.2M a year, as listed
Full record
Every detail in the company directory

Biotechnology in United Kingdom

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Epoch Biodesign in front of investors. Or tell us what we have wrong.